Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Co-administered Meningococcal and Pneumococcal Vaccines in Toddlers
NCT00758264Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Primary completion
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal disease, sponsored by GSK. Started Oct 2008; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00758264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758264.